Global Drug of Abuse Testing Market - 2023-2030

Global Drug of Abuse Testing Market - 2023-2030


Market Overview

The global drug of abuse testing market reached US$ 5878.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 9030.0 million by 2030. The market is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

The global drug of abuse testing market is also growing due to factors like the growth in drug-related mortality, strict laws requiring alcohol and drug testing, and rising government initiatives. The drug of abuse testing market will expand as drug overdose rates rise. Drug of abuse testing product developments and their upcoming medical approvals across countries are also creating a positive outlook for market growth.

Market Dynamics

The Increasing Government Initiatives And Novel Product Launches Drive The Drug Of Abuse Testing Market Growth.

Drug usage has been linked to a number of illegal behaviors that deplete a country's resources. Governments in both affluent and developing nations have been compelled by these causes to prosecute addicts. As a result, developed countries like the US have severe laws against drug abuse and mandate alcohol and drug testing. To prevent violence or accidents, testing for alcohol and drugs on the highways is growing in popularity in both developed and developing countries, which is aiding the market's overall expansion.

In order to maintain their experience and drug of abuse testing market shares, major players are therefore developing their line of products by releasing goods and updating software with novel components for drug abuse testing, which is an increasing trend in the market for drug abuse testing.

Finding drug testing techniques is also essential because they may encourage the use of drug testing kits and equipment, which would further the market's expansion. The increased need for addiction to drug treatment, the rising death rate connected to drug use, and expanding government activities are additional factors that are anticipated to favorably impact the growth of this market.

Growing R&D Expenditure And Technological Advancements Creates Lucrative Opportunities For Manufacturers.

Due to key players' significant investments in research and development capabilities for cutting-edge technical improvements, there is a developing market opportunity. By routinely detecting drug usage and evaluating the patient's status, a number of businesses are creating revolutionary technologies for treating drug addicts.

Rising technological developments in a variety of testing items, including immunoassay analyzers, chromatography equipment, assay kits and reagents, and breathalyzers, improve accessibility and make them more affordable for hospitals or workplaces. Demand for drug testing will rise as juvenile drug addiction rates rise. This element will present a chance for market expansion.

The Lack Of Awareness And Consideration Of Drug Testing Will Hamper The Growth Of The Market.

Although drug testing is not widely known or is viewed as an infringement on personal freedoms in some countries, the global market for illegal drug testing is predicted to grow. Market expansion is also constrained by DOA testing shortcomings, including its failure to detect low-dose designer medicines, and social problems associated with prescription drug misuse testing.

One of its key downsides is the lack of a correlation between concentrations of drugs and impairment in urine. Many laboratories have trouble identifying abused medications in blood because of the low drug levels.

COVID-19 Impact Analysis

The COVID-19 analysis includes the Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario in addition to pricing dynamics (including pricing change during and after the pandemic evaluating it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply due to trading restrictions, lockdown, and afterward issues), government initiatives (initiatives to reactivate a market, industry, or sector by government bodies), and manufacturers strategic initiatives.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global drug of abuse testing market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global drug of abuse testing market growth over the forecast period.

Segment Analysis

The global drug of abuse testing market is segmented based on product, sample type, end-user and region.

Immunoassay Analyzers Segment Accounts For 36.9% Of Market Share Owing To Rising Drug Addiction.

Hospital or clinical laboratories utilize immunoassay analyzers to execute automated biochemical tests to find the presence and quantity of chemicals in the samples. Immunoassay analyzers are capable of conducting a wide range of tests, including those for cancer markers, infectious disease diagnosis, cardiac analysis, therapeutic medication monitoring, and allergy testing.

An immunoassay analyzer can handle a sample in two different ways: continuous access sampling and random sampling. The samples can go through various immunoassay tests for ion capture, chemiluminescence, fluorescence polarization and microparticle enzyme. The types of tests or reagents required, if automatic repetition and dilution are necessary, and the speed at which the tests may be conducted should all be taken into account when selecting an immunoassay analyzer.

Geographical Analysis

North America Accounted For Approximately 37.6% Of The Market Share Owing To The Strong Presence Of Major Players And Increasing Technological Advancements.

Manufacturers have chances to expand their operations in this region because of the rising demand for drug of abuse testing products with advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of drug of abuse testing products, which has increased the demand.

North America has a large number of producers and suppliers, and as a result of the swift economic development of the area, industrial production has increased, fueling the demand for drug of abuse testing products. Rising new product launches for using drug of abuse testing by key companies for forensic labs or hospitals will drive the market growth.

Growth is also fueled by rising technological advancements, regulatory approvals, and novel product launches. Individuals are becoming more aware of the consequences in people with drug or alcohol addiction, leading to the expansion of the market in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the drug of abuse testing market include Abbott Laboratories, Laboratory Corporation of America Holdings (Labcorp), Beckman Coulter, Inc., Dragerwerk AG & Co. KGaA, Randox Laboratories Ltd., Quest Diagnostics Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, United States Drug Testing Laboratories Inc. (USDTL) and F. Hoffmann-La Roche Ltd among others.

Why Purchase the Report?
• To visualize the global drug of abuse testing market segmentation based on sample type, product, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of drug of abuse testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global drug of abuse testing market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Sample Type
3.2. Snippet by Product
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing government initiatives
4.1.1.2. Stringent law mandating alcohol and drug testing
4.1.2. Restraints
4.1.2.1. The lack of awareness and consideration of drug testing
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Sample Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
7.1.2. Market Attractiveness Index, By Sample Type
7.2. Urine *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Saliva
7.4. Hair
7.5. Blood
8. By Product
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
8.1.2. Market Attractiveness Index, By Product
8.2. Immunoassay Analyzers *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Chromatography Instruments
8.4. Breath Analyzers
8.5. Assay Kits and Reagents
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Forensic Laboratories
9.4. Workplaces
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
Australia
10.5.6.4. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Abbott Laboratories *
12.1.1. Company Overview
12.1.2. Sample Type Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Beckman Coulter, Inc.
12.3. Laboratory Corporation of America Holdings (Labcorp)
12.4. Dragerwerk AG & Co. KGaA
12.5. Quest Diagnostics Inc.
12.6. Randox Laboratories Ltd.
12.7. Thermo Fisher Scientific Inc.
12.8. United States Drug Testing Laboratories Inc. (USDTL)
12.9. Siemens Healthineers
12.10. F. Hoffmann-La Roche Ltd
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings